1: Frost MJ, Ferrao PT, Hughes TP, Ashman LK. Related Articles, Links
Juxtamembrane mutant V560GKit is more sensitive to Imatinib (STI571) compared with wild-type c-kit whereas the kinase domain mutant D816VKit is resistant.
Mol Cancer Ther. 2002 Oct;1(12):1115-24.
PMID: 12481435 [PubMed - in process]
2: Pane F, Intrieri M, Quintarelli C, Izzo B, Muccioli GC, Salvatore F. Related Articles, Links
BCR/ABL genes and leukemic phenotype: from molecular mechanisms to clinical correlations.
Oncogene. 2002 Dec 9;21(56):8652-67.
PMID: 12476311 [PubMed - in process]
3: Skorski T. Related Articles, Links
BCR/ABL regulates response to DNA damage: the role in resistance to genotoxic treatment and in genomic instability.
Oncogene. 2002 Dec 9;21(56):8591-604.
PMID: 12476306 [PubMed - in process]
4: Nimmanapalli R, Bhalla K. Related Articles, Links
Novel targeted therapies for Bcr-Abl positive acute leukemias: beyond STI571.
Oncogene. 2002 Dec 9;21(56):8584-90.
PMID: 12476305 [PubMed - in process]
5: Siraj AK, Ozbek U, Sazawal S, Sirma S, Timson G, Al-Nasser A, Bhargava M, El Solh H, Bhatia K, Gutierrez MI. Related Articles, Links
Preclinical Validation of a Monochrome Real-Time Multiplex Assay for Translocations in Childhood Acute Lymphoblastic Leukemia.
Clin Cancer Res. 2002 Dec;8(12):3832-3840.
PMID: 12473597 [PubMed - as supplied by publisher]
Time used: 47 miliseconds.

Webpage designed by Dr. Xueliang Fang, last updated on 3/10/2005